Supramolecular Polymer Chemistry
A R T I C L E S
of dichloromethane and 60 mL of water. The organic layer was
combined with the retained residue and washed with 100 mL of a
solution prepared by saturation with sodium bicarbonate and addition
of 1 mL of glacial acetic acid. The collected organic layer was dried
over Na2SO4, and the solvent was removed under reduced pressure.
The crude product was purified by column chromatography over silica
gel (5-10% EtOAc-CH2Cl2) to afford 2.40 g (93%) of the desired
0.52 g (13 mmol) of sodium hydride as a 60% (w/w) suspension in oil
and the mixture was heated to reflux for 10 min at which time hydrogen
gas evolution ceased. To the resulting turbid mixture was added 2 g
(7.35 mmol) of bis(N-ethyl guanidinium) sulfate and the mixture was
heated to reflux for 20 min. The resulting turbid solution was separated
from the insoluble salts by pipet and added to 1.7 g (2.2 mmol) of 13a
and then sealed into a glass tube. The resulting yellow mixture was
heated in a 160 °C oil bath for 24 h. All the initial 13a dissolved after
ca. 20 min, and a new solid formed after ca. 12 h. The resulting yellow
suspension was cooled to room temperature, and the solvent was
removed in vacuo. The resulting yellow residue was partitioned between
150 mL of dichloromethane and 120 mL of a saturated aqueous solution
of sodium bicarbonate and 2 mL of a 6 N aqueous solution of
hydrochloric acid. The collected organic layer was dried over Na2SO4,
and the solvent was removed in vacuo. The product was further purified
by column chromatography over silica gel (5% methanol-dichloro-
methane to 10% methanol-dichloromethane) followed by preparative
size exclusion chromatography in toluene over S-X beads (Bio-Rad;
400-14 000 Da) to afford 1.1 g (64%) of the desired 2a as a yellow
1
product as white needle crystals: mp 125-126 °C. H NMR: δ 8.63
(s, 1H, H-4), 8.42 (d (br), 1H, H-5), 8.20 (d, J ) 9.2, 1H, H-6), 7.78
(s, 1H, NH), 4.46 (q, J ) 7.4, 2H, OCH2CH3), 1.55 (s, 9H, tert-Bu),
1.44 (t, J ) 7.1, 3H, OCH2CH3); 13C NMR: δ 168.5, 156.4, 154.9,
151.8, 151.6, 141.6, 139.4, 123.6, 117.6, 114.4, 82.5, 62.6, 28.1, 14.2.
MS (FAB): 352.10 (M + H)+. HRMS (FAB). Calcd for C16H19-
ClN3O4: 352.1064. Found: 352.1062. Anal. Calcd for C16H18N3O4Cl:
C, 54.63; H, 5.16; N, 11.94; Cl, 10.08. Found: C, 54.45; H, 5.13; N,
11.80; Cl, 10.32.
2-Chloro-3-carbethoxy-7-amino-N-tert-BOC-N-(3′,5′-bis(3′′,5′′-di-
(tert-butyl)benzyloxy)benzyl)-1,8-naphthyridine (12a). A suspension
of 3.66 g (10.4 mmol) of chloronaphthyridine 10, 5.8 g (9.7 mmol) of
11a, 9.8 g (71 mmol) of potassium carbonate, and 136 mg (0.6 mmol)
of 18-crown-6 in a mixture of 60 mL of THF and 110 mL of acetonitrile
was heated to reflux for 4 h at which time TLC indicated consumption
of starting materials. The resulting yellow suspension was cooled to
room temperature, and the solvent was removed at reduced pressure.
The resulting yellow residue was partitioned between 200 mL of water
and 260 mL of dichloromethane. The organic layer was washed with
200 mL of water and dried over Na2SO4, and the solvent was removed
in vacuo. The resulting yellowish solid was recrystallized from
heptane-toluene to afford 6.8 g (80%) of 12a as a white solid. An
analytically pure sample of 12a was obtained by preparative thin-layer
chromatography over silica gel (30% petroleum ether-dichloromethane
to dichloromethane to 10% ethyl acetate-dichloromethane): mp 210-
1
solid: mp 218-220 °C. H NMR (DMSO-d6): δ 10.75 (br, 1H, NH-
3), 8.50 (s, 1H, H-5), 8.02 (br s, 1H, NH-8), 7.93 (br d, 1H, H-7), 7.33
(t, J ) 1.7, 2H, H-4′′), 7.24 (d, J ) 1.7, 4H, H-2′′, H-6′′), 6.76 (d, J
) 8.0, 1H, H-6), 6.68 (d, J ) 1.9, 2H, H-2′, H-6′), 6.61 (t, 1H, H-4′),
6.50 (br s, 1H, NH-2), 5.01 (s, 4H, OCH2Ar), 4.63 (d, J ) 5.1, 2H,
8-N-CH2), 3.40 (quintet, J ) 5.9, 2H, 2-N-CH2), 1.27 (s, 36H, tert-
1
Bu), 1.16 (t, J ) 7.1, 3H, NCH2CH3); H NMR (deacidified CDCl3):
δ 13.95 (s, 1H, NH-3), 10.89 (s, 1H, NH-2), 10.33 (s, 1H, NH-8), 8.21
(s, 1H, H-5), 7.33 (s br, 2H, H-4′′), 7.28 (d, J ) 8.7, 1H, H-6), 7.20
(br s, 4H, H-2′′, H-6′′), 6.76 (d, J ) 8.7, 1H, H-7), 6.68 (d, J ) 1.9,
2H, H-2′, H-6′), 6.61 (t, J ) 1.9, 1H, H-4′), 4.93 (AB q, J ) 11, 4H,
OCH2Ar), 4.72 (br d, J ) 10.9, 1H, 8-N-CH2), 4.42 (br d, J ) 13.8,
1H, 8-N-CH2), 4.33 (br s,1H, 2-N-CH2), 4.19 (br s, 1H, 2-N-CH2), 1.47
(br, 3H, NCH2CH3), 1.26 (s, 36H, tert-Bu); 13C NMR: δ 165.4, 162.6,
162.4, 160.5, 160.0, 154.2, 150.9, 141.4, 139.1, 137.6, 135.6, 122.3,
122.2, 113.4, 109.6, 107.1, 105.7, 100.6, 70.9, 46.6, 35.4, 34.8, 31.4,
16.6; IR (deacidified CHCl3): 1688. MS (MALDI): 784.4 (M + H)+.
MS (FAB): 783.5 (M)+. Anal. Calcd for C49H62N6O3: C, 75.16; H,
7.98; N, 10.73. Found: C, 75.16; H, 7.79; N, 10.77.
1
211 °C. H NMR: δ 8.60 (s, 1H, H-4), 8.28 (d, J ) 8.8, 1H, H-5),
8.09 (d, J ) 8.8, 1H, H-6), 7.38 (t, J ) 1.5, 2H, H-4′′), 7.24 (d, J )
1.5, 4H, H-2′′, H-6′′), 6.67 (d, J ) 2.1, 2H, H-2′, H-6′), 6.53 (t, J )
2.1, 1H, H-4′), 5.48 (s, 2H, NCH2Ar), 4.94 (s, 4H, OCH2Ar), 4.45 (q,
J ) 7.1, 2H, OCH2CH3), 1.48 (s, 9H, tert-BuO), 1.44 (t, J ) 7.1, 3H,
OCH2CH3), 1.32 (s, 36H, tert-Bu); 13C NMR: δ 164.2, 164.0, 158.8,
154.7, 153.9, 151.1, 150.9, 141.3, 140.9, 137.5, 135.8, 123.9, 122.2,
121.1, 119.8, 117.6, 106.6, 100.5, 82.9, 70.8, 62.1, 49.4, 34.8, 31.4,
28.0, 14.1. Anal. Calcd for C53H68N3O6Cl: C, 72.45; H, 7.80; N, 4.78;
Cl, 4.04. Found: C, 72.65; H, 7.88; N, 4.61; Cl, 4.21.
2-Chloro-3-carbethoxy-7-amino-N-tert-BOC-N-(3′,5′-bis(3′′,5′′-
bis(3′′′,5′′′-di(tert-butyl)benzyloxy)benzyloxy)benzyl)-1,8-naphthyr-
idine (12b). Using the procedure described for 12a, a suspension of
0.352 g (1.0 mmol) of chloronaphthyridine 10, 1.255 g (1.0 mmol) of
11b (G2-Br), 0.966 g of potassium carbonate, and 14 mg of 18-crown-6
in a mixture of 6 mL of THF and 11 mL of acetonitrile afforded
yellowish oil, which was purified twice by column chromatography
2-Chloro-3-carbethoxy-7-amino-N-(3′,5′-bis-(3′′,5′′-di-tert-butyl)-
benzyloxy)benzyl-1,8-naphthyridine (13a). To a clear solution of 1.3
g (1.5 mmol) of 12a in 50 mL of reagent grade dichloromethane were
added 0.8 mL of trifluoroacetic acid. The solution was stirred overnight
at room temperature at which time it became pale yellow. The solution
was washed with 40 mL of a saturated aqueous solution of sodium
bicarbonate, collected, and dried over Na2SO4, and the solvent was
removed at reduced pressure. The resulting yellowish solid was
recrystallized from heptane-toluene to afford 1 g (86%) of the desired
13a as a white solid. An analytically pure sample of 13a was obtained
by column chromatography over silica gel (1-5% methanol-
1
(CH2Cl2-hexane ) 2:1) to give 0.72 g of 12b (47%). H NMR: δ
8.58 (s, 1H, H-4), 8.26 (d, J ) 9.0, 1H, H-5), 8.05 (d, J ) 9.0, 1H,
H-6), 7.40 (t, J ) 1.7, 4H, H-4′′′), 7.27 (d, J ) 1.7, 8H, H-2′′′, H-6′′′),
6.69 (d, J ) 2.4, 4H, H-2′′, H-6′′), 6.62 (t, 2H, H-4′′), 6.60 (d, 2H,
H-2′, H-6′), 6.49 (t, 1H, H-4′), 5.46 (s, 2H, NCH2), 4.98 (s, 8H,
Ar′′′CH2OAr′′), 4.93 (s, 4H, Ar′′CH2OAr′), 4.44 (q, J ) 7.0, 2H, OCH2-
CH3), 1.43 (s, 9H, tert-BuO), 1.42(t, J ) 7.0, 3H, OCH2CH3), 1.33(s,
72H, tert-Bu); 13C NMR: δ 164.0, 160.2, 160.1, 159.7, 154.6, 153.7,
151.0, 150.9, 141.3, 141.0, 139.0, 137.5, 135.5, 123.8, 122.2, 122.1,
117.5, 106.4, 106.2, 106.1, 101.3, 100.5, 82.8, 70.9, 69.9, 62.0, 34.7,
31.3, 27.9, 14.1; MS (MALDI): m/z 1527.65 (M + H)+; MS (FAB):
m/z 1528.0 (M + H)+. Anal. Calcd for C97H124ClN3O10: C, 76.27; H,
8.18; N, 2.75. Found: C, 76.69; H, 8.54; N, 2.31.
1
chloroform): mp 229-231 °C. H NMR: δ 8.44 (s, 1H, H-4), 7.77
(d, J ) 8.8, 1H, H-5), 7.42 (t, J ) 1.7, 2H, H-4′′), 7.27 (d, J ) 1.7,
4H, H-2′′, H-6′′), 6.72 (d, J ) 8.8, 1H, H-6), 6.68 (d, J ) 2.1, 2H,
H-2′, H-6′), 6.53 (t, J ) 2.1, 1H, H-4′), 4.82 (d, J ) 5.6, 2H, NCH2-
Ar), 4.98 (s, 4H, OCH2Ar), 4.42 (q, J ) 7.0, 2H, OCH2CH3), 1.43 (t,
J ) 7.1, 3H, OCH2CH3), 1.34 (s, 36H, tert-Bu); 13C NMR: (THF) δ
164.8, 161.9, 161.5, 158.6, 151.4, 150.9, 142.3, 141.9, 137.7, 137.6,
122.9, 122.4, 120.3, 116.3, 115.7, 107.8, 101.3, 71.3, 61.8, 46.0, 35.4,
31.8, 14.6. Anal. Calcd for C48H60N3O4Cl: C, 74.06; H, 7.77; N, 5.40;
Cl, 4.55. Found: C, 74.19; H, 7.89; N, 5.42; Cl, 4.73.
2-Chloro-3-carbethoxy-7-amino-N-(3′,5′-bis(3′′,5′′-bis(3′′′,5′′′-di-
tert-butyl)benzyloxy)benzyloxy)benzyl-1,8-naphthyridine (13b). Us-
ing the procedure described for 13a, a solution of 0.72 g of 12b in 20
mL of reagent grade CH2Cl2 and 0.5 mL of trifluoroacetic acid afforded
yellowish oil, which was purified by column chromatography (2%
1
2,8-Diamino-2-N-ethyl-8-N-(3′,5′-bis(3′′,5′′-di-tert-butyl)benzyloxy)-
benzylpyrimido(4,5-b)(1,8)naphthyridine-3H-4-one (2a). To a mix-
ture of 40 mL of THF and 40 mL of tert-butyl alcohol were added
MeOH-CHCl3) to give 0.30 g (45%) of 13b. H NMR: δ 8.44 (s,
1H, H-4), 7.76 (d, J ) 9.2, 1H, H-5), 7.40 (t, J ) 1.6, 4H, H-4′′′), 7.27
(d, J ) 1.7, 8H, H-2′′′, H-6′′′), 6.71 (d, J ) 2.4, 4H, H-2′′, H-6′′), 6.67
9
J. AM. CHEM. SOC. VOL. 124, NO. 46, 2002 13767